health information
Posts tagged Gilead
Gilead Terminates Phase II Clinical Trial Of GS 9450 In Patients With Chronic Hepatitis C
01 year ago
by admin
in Health Conditions
Gilead Terminates Phase II Clinical Trial Of GS 9450 In Patients With Chronic Hepatitis C
Gilead Sciences, Inc. (Nasdaq:GILD) today announced the company is stopping its ongoing Phase II clinical trial of GS 9450, an investigational caspase inhibitor, in patients with chronic hepatitis C. This decision follows reports of significant laboratory abnormalities and adverse events in a number of clinical study participants. Patient safety is Gilead’s top priority, and the company has …
Read more on Medical News Today
Gilead ends mid stage hepatitis C drug study
01 year ago
by admin
in Health Conditions
Gilead ends mid stage hepatitis C drug study
Gilead Sciences Inc. said Tuesday it stopped a mid stage clinical trial of an experimental hepatitis C drug because of the drug’s side effects.
Read more on AP via Yahoo! Finance
Gilead terminates phase II trial of GS 9450 in chronic Hepatitis C after adverse events
01 year ago
by admin
in Health Conditions
Gilead terminates phase II trial of GS 9450 in chronic Hepatitis C after adverse events
Gilead Sciences, Inc announced the company is stopping its ongoing phase-II clinical trial of GS 9450, an investigational caspase inhibitor, in patients with chronic hepatitis C. This decision follows reports of significant laboratory abnormalities and adverse events in a number of clinical study participants.
Read more on PharmaBiz
